Generation of high titers of recombinant aav vectors

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 7/01 (2006.01) C12N 15/12 (2006.01) C12N 15/49 (2006.01) C12N 15/86 (2006.01) C12N 15/864 (2006.01)

Patent

CA 2176117

AAV vectors may have utility for gene therapy but heretofore a significant obstacle has been the in- ability to generate sufficient quantities of such recom- binant vectors in amounts that would be clinically useful for human gene therapy application. Stable, helper-free AAV packaging cell lines have been elusive, mainly due to the activities of Rep protein, which down-regulates its own expression and reverses cellular immortaliza- tion. This invention provides packaging systems and processes for packaging AAV vectors that effectively circumvent these problems by replacing the AAV p5 promoter with a heterologous promoter (as depicted in the figure) and that allow for substantially increased packaging efficiency.

L'utilisation de vecteurs du virus adéno-associé (AAV) en thérapie génique a jusqu'ici rencontré un obstacle notable dans la mesure où il était impossible de générer de tels vecteurs recombinants en quantités suffisantes pour une utilisation d'ordre clinique en thérapie génique humaine. Les lignées cellulaires stables d'encapsidation d'AAV, sans cellules auxiliaires, se sont révélées difficiles à développer, principalement en raison des activités de la protéine Rep, qui sous-régule sa propre expression et inverse le processus d'immortalisation cellulaire. Cette invention permet d'obtenir des procédés et des systèmes d'encapsidation de vecteurs d'AAV qui permettent d'éviter ces problèmes en remplaçant le promoteur p5 d'AAV par un promoteur hétérologue (comme illustré dans la figure), et qui permettent en conséquence d'accroître sensiblement l'efficacité d'encapsidation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Generation of high titers of recombinant aav vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Generation of high titers of recombinant aav vectors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Generation of high titers of recombinant aav vectors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1721069

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.